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Most bioﬁlms involved in catheter-associated urinary tract infections (CAUTIs) are polymicrobial, with disease causing
(eg Escherichia coli) and atypical microorganisms (eg Delftia tsuruhatensis) frequently inhabiting the same catheter.
Nevertheless, there is a lack of knowledge about the role of atypical microorganisms. Here, single and dual-species
bioﬁlms consisting of E. coli and atypical bacteria (D. tsuruhatensis and Achromobacter xylosoxidans), were evaluated.
All species were good bioﬁlm producers (Log 5.84–7.25 CFU cm−2 at 192 h) in artiﬁcial urine. The ability of atypical
species to form a bioﬁlm appeared to be hampered by the presence of E. coli. Additionally, when E. coli was added to a
pre-formed bioﬁlm of the atypical species, it seemed to take advantage of the ﬁrst colonizers to accelerate adhesion, even
when added at lower concentrations. The results suggest a greater ability of E. coli to form bioﬁlms in conditions
mimicking the CAUTIs, whatever the pre-existing microbiota and the inoculum concentration.
Keywords: Escherichia coli; atypical species; multispecies bioﬁlms; urinary tract infections; urinary catheters
Introduction
Hospital-acquired (nosocomial) infections are frequently
related to bioﬁlms formed in medical devices, such as
prosthetic heart valves, cardiac pacemakers, urinary cath-
eters, contact lenses and orthopedic devices (Morris &
Stickler 1998; Hall-Stoodley et al. 2004; Campoccia
et al. 2006; Tenke et al. 2006; Silva et al. 2010). The
higher economic costs associated with these diseases is
due to long hospitalization periods for infected patients
(Ferrieres et al. 2007; Curtis 2008; Silva et al. 2010).
The most common nosocomial infections are urinary
tract infections (UTIs) (Klevens et al. 2007) and about
80% of these infections, known as catheter-associated
UTIs (CAUTIs), are related to the insertion of catheters
in the urinary tract (Doyle et al. 2001; Curtis 2008).
These medical devices are used in hospital and nursing
home settings to relieve urinary retention and inconti-
nence (Hall-Stoodley et al. 2004). However, in patients
with long-term urinary catheters, infection is inevitable
in most cases (Jacobsen et al. 2008).
CAUTIs originate from the colonization of the sur-
face of catheters by microorganisms. Indeed, urinary
catheters provide an attractive niche for bacterial coloni-
zation due to the intermittent ﬂow of warm nutritious
urine, leading to the formation and growth of a bioﬁlm
(Ganderton et al. 1992). Bioﬁlms have been described as
microbial communities attached to a surface and
embedded in extracellular polymeric substances (EPS)
(Costerton et al. 1987; Stewart & Franklin 2008). In this
mode of life, microorganisms can survive in hostile envi-
ronments, and are protected against external aggressive
factors encountered in host tissues (eg antibodies, and
phagocytes) or other environmentally-challenging condi-
tions (eg UV light, extreme temperatures, and shear
forces) (Donlan & Costerton 2002). In contrast to their
planktonic counterparts, cells in the bioﬁlm microenvi-
ronment are typically resistant to antibiotics (Lewis
2007). Consequently, infections on medical devices
associated with bioﬁlms are persistent and difﬁcult to
eradicate (Costerton 1999).
Recent studies involving urinary catheters have
shown that CAUTIs are mostly polymicrobial (Macleod
& Stickler 2007; Frank et al. 2009; Hola et al. 2010).
The potential pathogens involved in initial adhesion are
usually Staphylococcus epidermidis, Escherichia coli or
Enterococccus faecalis (Matsukawa et al. 2005); but sev-
eral others species (such as Pseudomonas aeruginosa,
Proteus mirabilis, Providencia stuartii and Klebsiella
pneumoniae) can appear in the later stages of infection,
in conjunction with initial colonizers (Matsukawa et al.
2005; Jacobsen et al. 2008). Furthermore, it was recently
observed that these disease causing microorganisms can
co-inhabit the catheter surface with other unusual micro-
organisms with unproven pathogenic potential (eg Delftia
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tsuruhatensis and Achromobacter xylosoxidans) (Frank
et al. 2009). While interactions of E. coli with other
common causes of UTIs have already been addressed
(Matsukawa et al. 2005; Ferrieres et al. 2007; Jacobsen
et al. 2008; Cerqueira et al. 2013); there is a lack of
knowledge about the possible role that these atypical
microorganisms play in the rate at which disease-
causing microorganisms adhere and form bioﬁlms and,
consequently, their effect on the outcome of CAUTIs.
Indeed, some studies have demonstrated recently, for
other pathologies, that the atypical microorganisms could
have important contributions in bioﬁlm infections (Lopes
et al. 2012, 2014).
Both disease-causing and atypical microorganisms
have in common the ability to form mono or multi-
species bioﬁlms on the surface of the urinary catheter
(Frank et al. 2009), which means that interactions
between the different bacterial populations are possible,
if not likely. For instance, some of these microorganisms
are able to degrade certain components of plastics (Patil
et al. 2006; Wan et al. 2007), which means that some
products of their metabolism might feed other microor-
ganisms (eg E. coli) and, eventually, they could act as
primary colonizers of the catheter. On the other hand, it
might be possible that the colonization by these atypical
microorganisms can prevent colonization by pathogenic
bacteria. Hence, understanding the role of atypical micro-
organisms in bioﬁlm dynamics might be crucial to help
in the development of novel strategies to prevent or min-
imize bacterial adhesion to catheters.
As such, in this study single-species (E. coli,
D. tsuruhatensis, A. xylosoxidans) and dual-species
(E. coli/D. tsuruhatensis, E. coli/A. xylosoxidans) bioﬁlm
formation in 96-well microtiter plates was evaluated. To
better mimic conditions found in urinary catheters, bio-
ﬁlms were formed in an artiﬁcial urine medium (AUM)
(Brooks & Keevil 1997) at 37°C. In order to understand
which type of interactions occur between different spe-
cies, dual-species bioﬁlms were compared with the ﬁt-
ness of individual bioﬁlm regarding: the total biomass
formed, total cell counts and cultivability values. Four
additional features were also explored: the growth rates
of each microorganism, siderophore production by
E. coli and atypical microorganisms, the antimicrobial
activity of bioﬁlm supernatants and the inﬂuence of a
pre-formed bioﬁlm on the adhesion and bioﬁlm forma-
tion of a second colonizer.
Materials and methods
Bacterial maintenance and inoculum preparation
For each experiment, E. coli CECT 434, A. xylosoxidans
B3 and D. tsuruhatensis BM90 were streaked from a
frozen stock (–80°C) on Tryptic Soy Agar (TSA) (Merck,
Darmstadt, Germany) and grown overnight at 37°C.
Subsequently, colonies from each species were used to
inoculate 75 ml of AUM. The cultures were incubated
overnight (16–18 h) at 37°C, under agitation (150 rpm).
The cell concentration was then assessed by optical den-
sity (OD) at 620 nm, and the inoculum was diluted in
AUM in order to obtain a ﬁnal concentration of 108 CFU
ml−1 or 102 CFUml−1. AUM was prepared as previously
described (Brooks & Keevil 1997), using the following
formulation in 1 l of distilled water: peptone 1 g (Merck),
yeast extract 0.05 g (Lioﬁlchem, Roseto degli Abruzzi,
Italy), lactic acid 1.1 mmol l−1 (Fluka, Portugal), citric
acid 0.4 g (VWR, Leuven, Belgium), sodium bicarbonate
2.1 g (Merck), urea 10 g (VWR), uric acid 0.07 g (VWR),
creatinine 0.8 g (Merck), calcium chloride.2H2 O 0.37 g
(Merck), sodium chloride 5.2 g (Merck), iron II sul-
fate.7H2 O 0.0012 g (Merck), magnesium sulfate.7H2O
0.49 g (Merck), sodium sulfate.10H2O 3.2 g (Merck),
potassium dihydrogen phosphate 0.95 g (Merck), di-potas-
sium hydrogen phosphate 1.2 g (Merck) and ammonium
chloride 1.3 g (Merck) (the pH was adjusted to 6.5).
Monospecies and multispecies bioﬁlms (E. coli
CECT 434/A. xylosoxidans B3; E. coli CECT 434/D.
tsuruhatensis BM90) were formed as described below.
Bioﬁlm formation assays
First, single-species bioﬁlms were formed to study the
bioﬁlm-forming ability of each species. For this, 200 μl
of each inoculum in AUM (108 CFUml−1 of initial con-
centration) were transferred into each well of a 96-well
tissue culture plate (Orange Scientiﬁc, Braine-l’Alleud,
Belgium). An additional experiment at an initial inocu-
lum concentration of 106 CFUml−1 was performed in
order to evaluate the inﬂuence of initial inoculation level
on bioﬁlm formation by the three species under study
(the results are presented in Supplemental material)
[Supplemental material is available via a multimedia link
on the online article webpage].
In order to understand how E. coli bioﬁlm formation
is affected by the presence of the atypical microorgan-
isms, a total of two species combinations (E. coli/A.
xylosoxidans; E. coli/D. tsuruhatensis) at the same initial
concentration (108 CFUml−1) were also studied. For
dual-species bioﬁlms, equal volumes of each single
culture (100 μl) at an initial concentration of
2 × 108 CFUml−1 were used.
Tissue culture plates were then placed in an incubator
(FOC 225I; VELP Scientiﬁca, Usmate, Italy) at 37°C,
under static conditions, for 8 days. Every 48 h the
medium was carefully replaced by fresh AUM. Wells
containing sterile AUM were used as a control. These
assays were performed in triplicate.
In order to test how a pre-formed single-species
bioﬁlm affects the subsequent adhesion of a second
colonizer, pre-colonization experiments were performed
























as follows. (i) Pre-colonization with atypical microorgan-
isms: wells of a 96-well tissue culture plate were pre-
colonized with atypical microorganisms (at an initial
concentration of 108 CFUml−1). After 24 h, the medium
was removed, the bioﬁlm was washed twice with sterile
saline solution 0.85% (v/v) and 200 μl of E. coli suspen-
sion (initial inoculum concentration of 102 CFUml−1)
were added. The same assay was performed but with ini-
tial concentrations of 102 CFUml−1 for the atypical
microorganisms and 108 CFUml−1 for E. coli. (ii) Pre-
colonization with E. coli: the experiments described in
(i) were repeated but microorganisms were added in
reverse sequence. (iii) Single-species bioﬁlms: single-
species bioﬁlms were developed to study bioﬁlm-forming
ability at a low initial concentration (102 CFUml−1).
These assays were used as controls to compare the
results obtained in bioﬁlm experiments (i) and (ii).
At selected time points (24, 48, 96 and 192 h), for-
mation of single and dual-species bioﬁlms was assessed
by crystal violet (CV) staining (for quantiﬁcation of bio-
mass formed), counts of colony forming units (CFUs)
(for cultivable cell counts) and DAPI (4′-6-diamidino-2-
phenylindole) staining (for total cell counts), as
described below.
Cultivability assessment
The number of cultivable bioﬁlm cells was determined by
CFUs. Brieﬂy, at each time point the bioﬁlm was washed
twice in 0.85% (v/v) sterile saline to remove loosely
attached cells. Subsequently, 200 μl of 0.85% (v/v) sterile
saline were transferred into each well of a 96-well plate.
The bioﬁlm was sonicated for 4 min (70W, 35 kHz,
Ultrasonic Bath T420, Elma, Singen, Germany) and then
resuspended by pipetting up and down three times. The
sonication step was previously optimized to ensure that
all cells were detached from the wells of the microtiter
plate, while avoiding cell disruption (data not shown).
Subsequently, 100 μl of the disrupted bioﬁlm were
serially diluted (1:10) in saline solution, and plated in
triplicate on TSA. The plates were incubated at 37°C for
12–16 h (E. coli), 24 h (D. tsuruhatensis) and 48 h
(A. xylosoxidans). For dual-species bioﬁlms, different
selective agar media were used for better discrimination
between the two species. MacConkey agar (Lioﬁlchem)
was used to assess E. coli counts. MacConkey agar is a
selective/differential medium, based on lactose fermenta-
tion, commonly used to discriminate Enterobacteriaceae.
D. tsuruhatensis and A. xylosoxidans presented slow
growth in this medium, but were easily distinguished due
to their non-lactose fermenting phenotype. The other
media used included: Cetrimide agar (Lioﬁlchem) for A.
xylodoxidans and Simmons Citrate agar (ammonium
dihydrogen phosphate 1 g l−1 [Merck]; di-potassium
hydrogen phosphate 1 g l−1 [Merck]; sodium chloride
5 g l−1 [Merck]; tri-sodium citrate 2 g l−1 [Sigma, St
Louis, MO, USA]; magnesium sulfate 0.2 g l−1 [Merck];
bromothymol blue 0.08 g l−1 [Sigma]; agar 13 g l−1
[Merck]) for D. tsuruhatensis. Neither of these two media
was able to recover E. coli cells. Afterwards, selective agar
plates were incubated at 37°C for 12–16 h (E. coli), 48 h
(A. xylosoxidans) and 72 h (D. tsuruhatensis). The
number of cultivable bacterial cells in bioﬁlms was deter-
mined and expressed per area of well in contact with
AUM (log CFU cm−2).
As a control test, the selective medium recovery
capacity for each microorganism was compared with
TSA. With this purpose, one of the experiments in pure
culture for each species was performed in the corre-
sponding selective/differential medium and in TSA. No
signiﬁcant differences were found between the CFU
counts in TSA and in the selective/differential media
used (data not shown).
Biomass quantiﬁcation by the CV assay
The biomass of single and dual-species bioﬁlms was
quantiﬁed by the CV staining method (Stepanovic et al.
2000). Brieﬂy, the washed bioﬁlm was ﬁxed with 250 μl
of 99% (v/v) ethanol for 15 min. Subsequently, the etha-
nol was removed and plates were allowed to air-dry.
Then ﬁxed bioﬁlms were stained with 250 μl of CV
(Merck) for 5 min. The wells were washed three times
with water. The plates were air dried and the dye bound
to the adherent cells was resuspended by adding 200 μl
of 33% (v/v) glacial acetic acid (Merck). Finally, plates
were placed in agitation up to 2 min and the OD mea-
sured at 570 nm using a microtiter plate reader (Spectra
Max M2, Molecular Devices, Sunnyvale, CA, USA).
DAPI staining
To assess total bacterial cell counts in single-species and
dual-species bioﬁlms, 100 μl of the sonicated cell sus-
pensions were ﬁltered in a black Nucleopore polycarbon-
ate membrane (Ø 25 mm) with a pore size of 0.2 μm
(Whatman, Maidstone, UK). Subsequently the membrane
was stained with DAPI (0.2 mg ml−1) (Merck) and left
for 10 min in the dark. Then, the membrane was placed
on a microscope slide. Finally, a drop of immersion oil
(Merck) was added and the membrane covered with a
coverslip. Cells were analyzed using a Leica DM LB2
epiﬂuorescence microscope connected to a Leica
DFC300 FX camera (Leica Microsystems, Wetzlar,
Germany). The optical ﬁlter combination for optimal
viewing of stained preparations (Chroma 61,000-V2),
consisted of a 545/30 nm excitation ﬁlter combined with
a dichromatic mirror at 565 nm and suppression ﬁlter
610/75. For image capture, Leica IM50 Image Manager

























area of 6.03 × 10−5 cm2 were counted and the average
was used to calculate the total cells per cm2.
Determination of bacterial growth rates
The growth rate for each species at 37°C on AUM was
determined. For this, cells were grown overnight (16–18 h).
Subsequently, cells were diluted in order to obtain a ﬁnal
OD (620 nm) of 0.1, incubated at 37°C, and 150 rpm. The
OD at 620 nm was measured at different time points until
the stationary stage was reached.
Siderophore production
Siderophore production by the studied microorganisms
was assessed by using the chrome azurol S (CAS) solid
medium assay, prepared as described by Schwyn and
Neilands (1987). Following incubation at 37°C for 24 h,
plates were analyzed for the presence of growth and
orange halos.
Antimicrobial activity of bioﬁlm supernatants
The presence of antimicrobial activity in bioﬁlm superna-
tants was assessed on lawns of E. coli and the two spe-
cies of atypical microorganisms. In order to collect the
bioﬁlm supernatants, single and dual-species bioﬁlms
were prepared according to the methodology described
above. After 72 h, supernatants were recovered, ﬁltered
(0.22 μm ﬁlter, Frilabo, Maia, Portugal) and kept at –
20°C. In order to test for possible contaminations, 10 μl
of these supernatants were placed on TSA for 24 h at
37°C. Lawns of each of the microorganisms were laid
onto TSA, using cotton swabs and allowed to air-dry.
Then, 10 μls of each supernatant was applied onto the
lawns, and left to air-dry. Afterwards, the plates were
incubated for 24 h at 37°C. The formation of halos was
indicative of the presence of antimicrobial activity.
Determination of the ﬁtness and malthusian parameter
The ﬁtness of E. coli relative to the atypical species
(WE. coli), determined for each dual-species bioﬁlms, was
estimated as the ratio of the malthusian parameters (m)
of each population (Lenski et al. 1991). The malthusian
parameter is deﬁned as the average rate of increase and
was calculated for both species over the time,
m ¼ ln ½N ðtfinalÞ= N ðtinitialÞ = tfinal (1)
where N is the value of CFU cm−2 present in the bioﬁlm
at initial time and ﬁnal time points. The relative ﬁtness
of E. coli was determined as,
WE:coli ¼ mE:coli=matypical species (2)
resulting in a ﬁtness of 1 when competing species are
equally ﬁt.
For pre-colonization experiments, in order to under-
stand the effect of a pre-colonized surface on the initial
adhesion of a second species, the malthusian parameter
of the added microorganism was calculated after 48 h of
its addition.
Statistical analysis and data accommodation
Results were compared using one-way analysis of vari-
ance (ANOVA) by applying Levene’s test of homogene-
ity of variance and the Tukey multiple-comparisons test,
using SPSS software (Statistical Package for the Social
Sciences, Chicago, IL, USA). All tests were performed
with a conﬁdence level of 95%. All raw data derived
from this study are stored at the BiofOmics platform
(http://biofomics.org) (Lourenco et al. 2012).
Results and discussion
Single and dual-species bioﬁlm experiments
It is now known that CAUTI-associated bioﬁlms often
involve more than one microbial species, causing what
can be deﬁned as a polymicrobial disease (Macleod &
Stickler 2007; Frank et al. 2009; Hola et al. 2010). As
E. coli is one of the main pathogens involved in these
infections (Svanborg & Godaly 1997; Hedlund et al.
2001; Ronald 2002; Niveditha et al. 2012), it would be
expected that the bioﬁlm-forming ability of this microor-
ganism would surpass those exhibited by atypical micro-
organisms. The assessment of the bacterial growth rate
in AUM has shown that the atypical microorganisms
were found to be slow-growing (values of growth
rates: 0.374 h−1 for D. tsuruhatensis; 0.3107 h−1 for
A. xylosoxidans) when compared to E. coli (0.4838 h−1).
Interestingly, this behavior was not observed for sin-
gle-species bioﬁlms, either in terms of bioﬁlm biomass
(Figure 1a), cultivable cells (Figure 1b) or total cells
(Figure S1). Higher biomass values were observed for A.
xylosoxidans, which reached an OD of ~5 at 192 h, when
compared with D. tsuruhatensis and E. coli (OD ~1.4
and ~2.4 at 192 h, respectively). Moreover, for
A. xylosoxidans values, this biomass difference was sta-
tistically signiﬁcant at 192 h (p < 0.05).
Regarding cultivability, no signiﬁcant differences were
found for E. coli, A. xylosoxidans or D. tsuruhatensis,
with CFU counts ranging between log 6.61 and log 7.25
CFU cm−2 (p > 0.05) (Figure 1b).
All species presented similar values for total cells for
the different time points (between log 6.76 and log
7.50 cells cm−2) (Figure S1) and, as expected, the CFU
counts were always lower than the DAPI counts. In
general, the averages of cells detected by cultivability
























(Figure 1c) for E. coli and A. xylosoxidans were high,
but for A. xylosoxidans, the loss of cultivability was
observed over time (77.2% at 24 h vs 36.6% at 192 h,
p > 0.05). For D. tsuruhatensis, the percentages obtained
were always lower than those observed for the other two
species (34.2% at 192 h, p > 0.05).
Regarding the species interaction in dual-species
bioﬁlms, to better summarize the results (Figure S2) and
visualize the inﬂuence of the atypical species on E. coli
bioﬁlm formation, the relative ﬁtness of E. coli in dual-
species bioﬁlms (Figure 2) was determined. In the pres-
ence of D. tsuruhatensis and A. xylosoxidans, the ﬁtness
of E. coli slightly increased over the time, reaching a
value of 1.12 (p < 0.05) and 1.07, respectively, after
192 h. These conclusions can be observed in more detail
in the CV and cultivability graphs (Figure S2). CV
assays for dual-species bioﬁlms showed that when
E. coli is co-cultured with the atypical microorganisms
the total biomass proﬁles tended to be more similar to
that of E. coli single-species bioﬁlm (Figure S2a, b). The
data for cultivability assays in dual-species bioﬁlms con-
ﬁrm that the ability of E. coli to form bioﬁlms does not
seem to be inﬂuenced by the presence of the other spe-
cies (Figure S2e, f). In addition, dual-species bioﬁlms
present similar values for total cells for the different time
points (Figure S3) and, as expected, the CFU counts
were always lower than the DAPI counts. However, it
should be mentioned that the observations described here
might be limited to the inoculum concentrations used in
this study. To clarify this point, the inﬂuence of the
Figure 1. Bioﬁlm formation for single-species bioﬁlms. Values for (a) total biomass; (b) cultivability; and (c) percentages of cells


























initial inoculation level (106 CFUml−1 vs 108 CFUml−1)
on bioﬁlm formation was evaluated (Figure S4). No
signiﬁcant differences were found for E. coli (p > 0.05
for each point), which indicates that the initial inoculum
concentration did not seem to have an inﬂuence on
E. coli attachment and accumulation over time
(Figure S4a). On the other hand, for D. tsuruhatensis
and A. xylosoxidans single-species bioﬁlm formed at an
initial concentration of 106 CFUml−1, and lower cultiva-
bility values were observed for up to 24 h and up to 48 h,
respectively, reﬂecting a delay in their bioﬁlm formation.
However, it does not affect the ﬁnal bioﬁlm concentration,
which reached the same values (Figure S4b, c).
It is well known that, in multispecies bioﬁlms, the
interactions may encourage the coexistence (synergistic
interaction) or confer advantage to one species, inhibiting
the growth of others (antagonistic interaction) (Harrison
2007; Hibbing et al. 2010; Elias & Banin 2012). In order
to explain the possible interaction between E. coli and
atypical species in dual-species bioﬁlm, four additional
features were analyzed: the antimicrobial activity of bio-
ﬁlm supernatants in single and dual-species bioﬁlms,
siderophore production, the growth rate of each species,
and the effect of a pre-formed bioﬁlm on E. coli bioﬁlm
formation.
Antimicrobial activity of bioﬁlm supernatants and
siderophore production
An important factor in determining the dominant species
within a mixed bioﬁlm is the production of antimicrobial
compounds, which might provide an advantage to the
producer species by interfering or killing the neighboring
microorganisms (Hibbing et al. 2010). However, in the
present work, the examination of antimicrobial com-
pounds in bioﬁlm supernatants, either from single or
dual-species bioﬁlms, suggested that none of the micro-
organisms secreted compounds clearly able to inﬂuence
the growth of the others. It might be possible that anti-
microbial compounds are present at very low concentra-
tions, as usually happens for the most part in the case of
secondary metabolites; which would also appear as a
negative result. Also, some other molecules that interfere
with non-essential processes (eg quorum sensing mole-
cules), are not detected in this type of assay. Nonethe-
less, the complete absence of any inhibitory signal
suggests that the observed decrease in the atypical micro-
organisms when co-cultured with E. coli is probably not
due to the production of antimicrobial compounds by
E. coli.
Other type of competitive interaction can be observed
in mixed bioﬁlms, in which one microorganism can
sequestrate a limited and essential nutrient, facilitating its
dominance over the other species (Hibbing et al. 2010).
An example of this competitive behavior involves iron
sequestration by the production, release and uptake of
siderophores (Grifﬁn et al. 2004; Weaver & Kolter 2004;
Joshi et al. 2006; Smith et al. 2006; Hibbing et al.
2010). Siderophores are molecules secreted under low
iron availability and are used by microorganisms to
sequester the iron available in the medium (Ratledge &
Dover 2000; Andrews et al. 2003; Hibbing et al. 2010).
The importance of iron acquisition has been reported for
the survival of uropathogenic E. coli during CAUTIs
development (Snyder et al. 2004; Jacobsen et al. 2008).
Considering the low iron concentration in urine and its
importance for microorganism growth and survival dur-
ing CAUTIs (Shand et al. 1985; Jacobsen et al. 2008),
this nutrient is expected to be consumed by microorgan-
isms with a high ability to produce or utilize sidero-
phores, limiting it to the other microorganisms. The CAS
agar results indicated that E. coli produces high levels of
siderophores. A. xylosoxidans and D. tusuruhatensis pro-
duced siderophores at lower levels (Figure 3). Thereby,
when E. coli is co-cultured with these atypical species in
AUM it can sequestrate iron molecules, providing this
microorganism with an advantage in iron-depleted condi-
tions, such as during CAUTIs.
Pre-colonization assays
Dual-species bioﬁlm experiments suggested that E. coli
predominates over the co-cultured species. However,
nothing is known about the ability of this bacterium to
adhere to a pre-colonized surface by the two atypical
species. To conﬁrm whether A. xylosoxidans or
D. tusuruhatensis bioﬁlms affect E. coli colonization,
24 h bioﬁlms of A. xylosoxidans or D. tusuruhatensis
were formed and then E. coli was added. These
Figure 2. Relative ﬁtness of E. coli in dual-species bioﬁlms.
Fitness of E. coli was determined in the presence of atypical
species (D. tsuruhatensis and A. xylosoxidans) with simulta-
neous addition of the bacteria at the same initial concentration
(108 CFUml−1). Data are means of three independent experi-
ments and error bars represent the SD.
























experiments were performed with different inoculum
concentrations (108 CFUml−1 and 102 CFUml−1) to
determine whether the inoculation level inﬂuenced the
adhesion of a second species to the bioﬁlm.
The addition of E. coli to a pre-formed bioﬁlm did
not lead to signiﬁcant changes in the total biomass com-
pared to experiments with synchronized addition of spe-
cies (Figure S5). When E. coli was added to 24 h
bioﬁlms of the atypical microorganisms, the biomass
proﬁle was similar to experiments with synchronized
addition of species, regardless of the inoculation propor-
tion between the two species. Also, in dual-species bio-
ﬁlms, the concentration of the initial inoculum did not
seem to have a great deal of inﬂuence on biomass
production over time (Figures S5 and S6).
To better understand the possible role that a pre-
colonized surface has on the rate at which species adhere
and grow, the malthusian parameter of the microorgan-
ism added to a pre-formed bioﬁlm was determined. This
parameter reﬂects the average rate of increase of each
species (Lenski et al. 1991). Interestingly, the results
show that when a low initial concentration (102 CFU
ml−1) of any of the microorganisms is added to a pre-
formed bioﬁlm, the population of this species increases
more rapidly when compared with the corresponding
single-species bioﬁlm (Figures 4, S7 and S8). Several
bioﬁlms found in both environmental and clinical
settings are recognized as multispecies structures
(Hall-Stoodley et al. 2004), and this fact suggests that
this diversity provides some advantages for these com-
munities. It is known that diversity generally protects
communities from unstable environmental conditions
and, thus, it is likely that bacteria favor the development
of multispecies structures (Donlan & Costerton 2002).
Why the apparent induction of multispecies populations
happened in the speciﬁc case of the present study
remains unclear. It may be, for instance, that the mainte-
nance of atypical species, even at low densities, might
be beneﬁcial for E. coli if any environmentally challeng-
ing condition occurs. Alternatively, or in addition, some
of these atypical microorganisms are able to degrade cer-
tain components of plastics (Patil et al. 2006; Wan et al.
2007), which means that the products of their metabo-
lism might be able to feed E. coli, explaining why
E. coli beneﬁts when it is co-cultured with atypical
microorganisms. However, despite the suitability of the
96-well microtiter plates to simulate the conditions found
in catheter-associated urinary tract bioﬁlms (Moreira
et al. 2013), the results of the present work should be
replicated using catheter-like materials (eg silicones and
latex rubber). This would allow conﬁrmation of whether
these atypical microorganisms are able to degrade certain
components of catheters under conditions found in
bioﬁlms associated with CAUTIs.
Taken together, these data seem to indicate that spe-
cies behavior in dual-species bioﬁlm is also dependent
Figure 3. Screening for siderophore production using CAS
agar plates. (a) On CAS agar, an orange halo surrounding the
colony indicates that E. coli produces high levels of sidero-
phores. The presence of growth without an orange halo indi-
cates that (b) D. tusuruhatensis and (c) A. xylosoxidans
produce siderophores to a lesser extent.
Figure 4. Values of the malthusian parameter for pre-coloniza-
tion experiments. The malthusian parameter of the second
microorganism added to a pre-formed bioﬁlm was determined
between time 0 and 48 h. Values of the malthusian parameter
for single-species bioﬁlm of each microorganism were deter-
mined for comparative purposes. SB = single-species bioﬁlm;

























on the population size and the physical space available.
When cellular concentrations in bioﬁlm are low, compe-
tition was not observed; instead, species might beneﬁt
from the presence of another colonizer (Figure 4).
Indeed, the adhesion of a second colonizer added at low
concentration was accelerated. On the other hand, when
cellular concentrations reached higher values, the popula-
tion of atypical species slightly decreased (Figures S2c,
d, S7d), which suggests that competition had taken
place.
A good example of multispecies bioﬁlm advantages
is provided in the work of Lopes et al. (2012). They
studied the role of two novel microorganisms isolated
from cystic ﬁbrosis specimens. When P. aeruginosa was
co-cultured with atypical microorganisms (Inquilinus
limosus and Dolosigranulum pigrum), an increase in the
tolerance of the dual-species bioﬁlms to most antibiotics
was observed (Oliveira et al. 2012). In another study,
Sibley et al. (2008) reported that an avirulent species in
combination with P. aeruginosa isolated from cystic
ﬁbrosis ﬂora had the ability to enhance the pathogenicity
of this microorganism and, consequently, to inﬂuence the
outcome of the infection. In addition, other studies also
reported the importance of atypical pathogens (eg
Burkholderia cepacia, Stenotrophomonas maltophilia
and A. xylosoxidans) in clinical outcomes of cystic ﬁbro-
sis (de Vrankrijker et al. 2010; Waters 2012).
D. tusuruhatensis and A. xylosoxidans have been iso-
lated from diverse clinical sources (Lambiase et al. 2011;
Preiswerk et al. 2011; Amoureux et al. 2012; Waters
2012; Ciofu et al. 2013), including CAUTIs (Frank et al.
2009). Thus, it is expected that these unusual species
interact with the disease-causing agents and have an
important role in bioﬁlm architecture and physiology.
Conclusions and future work
By combining the results obtained in this work, a sche-
matic representation of dual-species bioﬁlm formation
showing the main factors involved in the predominance
and coexistence of E. coli with atypical species is pro-
posed (Figure 5).
E. coli presented a greater ability to form a bioﬁlm
in conditions mimicking CAUTIs, whatever the pre-
existing microbiota, which helps explain the high prev-
alence of E. coli in CAUTIs. Nonetheless, despite the
probable non-pathogenic nature of the two atypical
species, they were also good bioﬁlm producers on
abiotic surfaces. Additionally, the coexistence of
E. coli with the two atypical species within dual-
species bioﬁlm structures was proved and pre-coloniza-
tion with these species seemed to promote adhesion of
the pathogen.
The results also suggest that the behavior of species
in dual-species bioﬁlm might be dependent on the popu-
lation size and the space available for growth. Since
diversity within the bioﬁlm population usually indicates
higher chances of persisting in detrimental conditions,
Figure 5. Schematic representation of dual-species bioﬁlm formation showing the main factors involved in the predominance and
coexistence of E. coli with atypical species. Representation of the interaction between E. coli and atypical microorganisms (a) in
dual-species bioﬁlm with simultaneous addition of the species; (b) in dual-species bioﬁlm subjected to a pre-colonization step with
the atypical species, followed by the addition of the E. coli; and (c) in dual-species bioﬁlms subjected to a pre-colonization step with
E. coli, followed by the addition of the atypical species. Regardless of the initial conditions, the dual-species bioﬁlm tended to a ﬁnal
state of coexistence where E. coli predominated over the atypical species (GR = growth rate; SD = siderophores).
























coexistence seems to be preferred. But, for mature stages
of bioﬁlm formation, competition might take place and
then the higher ﬁtness of E. coli in this environment
becomes evident. The high growth rate of E. coli in
AUM, in association with high levels of siderophore pro-
duction, helps to explain the ability of this bacterium to
outcompete atypical species.
In the future, further insights into the resistance pro-
ﬁle of these structures might help to provide an adequate
treatment for each patient, with an accurate selection of
antibiotic and dosage necessary to treat a particular
infection originating from a mixed bioﬁlm (Frank et al.
2009).
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